Clinical Trials Browser

Phase 1 × Breast Neoplasms × vistusertib × Clear all

NCT02208375 2025-12-31

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Phase 1 Active not recruiting

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02599714 2024-06-06

PASTOR

Phase 1 Completed

Breast Neoplasms